Dataset
patent-linked-siRNA
🧬 Dataset Summary Patent-linked nucleotide sequence records focused RNAi therapeutics patent portfolio. Each record pairs a raw nucleotide sequence with its source patent number, publication date, and global patent family coverage. 🚀 Key Features Patent Linkage: Each sequence is tied to a patent number (pn) and publication date (pbdt), enabling sequence-to-IP traceability. Global Family Coverage:
Data preview
Dataset card
patent-linked-siRNA is listed on Hugging Face by PatSnap.
The recorded metadata describes estimated at millions of records. The listing has drawn 71 downloads and 0 likes on Hugging Face.
The data
The dataset is sized at millions of records.
The source tags it with biology, siRNA and oligonucleotide-therapeutics.
Documentation & references 2
Related datasets
Browse moreParsed eligibility criteria from 13,229 ClinicalTrials.gov studies representing the candidate pool gathered by two first-stage retrievers during TREC Clinical Trials 2021–2023, formatted as typed entity-relation graphs for reranking models.
The clinical-trials-patient-graphs dataset is a small tabular collection of patient-level clinical records distributed in Parquet format by the 2001jdev publisher. It organizes entities and relations extracted from trial data into structured rows spanning 2021 through 2023.
This dataset is a parsed snapshot of ClinicalTrials.gov records, distributed in Parquet format on the Hugging Face Hub under an unspecified license. It contains roughly 52,000 trial entries drawn from public registry filings.
clinical-trials-trec-qrels is a tabular relevance-judgment file distributed by the 2001jdev user on the Hugging Face Hub. It maps clinical-trial topic identifiers to NCT registry IDs with graded relevance scores.
The clinical-trials-trec-topics dataset is a small tabular collection of clinical-trial topic records distributed in Parquet format on the Hugging Face Hub. It appears to be derived from TREC clinical-trial retrieval topics, with rows partitioned by year.
SEC EDGAR 10-K & 10-Q financial statements for 2,600+ NASDAQ companies.
Discussion
Questions or observations about this dataset? Join the conversation on X.
No comments yet. Start the conversation on X.